Showing results (441-450 of 630) with videos related to
Sort By:
Pageof 63
American Journal of Clinical Dermatology|December 13, 2022
Early Itch Response with Abrocitinib Is Associated with Later Efficacy Outcomes in Patients with Moderate-to-Severe Atopic Dermatitis: Subgroup Analysis of the Randomized Phase III JADE COMPARE TrialSonja Ständer, Shawn G Kwatra, Jonathan I Silverberg, et al.The British Journal of Dermatology|February 5, 2020
Validation of Patient-Reported Outcomes Information System Sleep Disturbance and Sleep-Related Impairment in adults with atopic dermatitisD K Lei, M Yousaf, S R Janmohamed, et al.The British Journal of Dermatology|April 20, 2022
The Validated Investigator Global Assessment for Atopic Dermatitis (vIGA-AD™): a clinical outcome measure for the severity of atopic dermatitisEric L Simpson, Robert Bissonnette, Amy S Paller, et al.Archives of Dermatological Research|March 27, 2021
Statins are associated with increased risk of squamous cell carcinoma of the skin: a whole-population study from IcelandJonas A Adalsteinsson, Sonal Muzumdar, Reid Waldman, et al.Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology|January 9, 2021
Atopic dermatitis in the pediatric population: A cross-sectional, international epidemiologic studyJonathan I Silverberg, Sebastien Barbarot, Abhijit Gadkari, et al.Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology|June 17, 2020
Association of itch triggers with atopic dermatitis severity and course in adultsJonathan I Silverberg, Donald Lei, Muhammad Yousaf, et al.Journal of the American Academy of Dermatology|May 20, 2020
Association of atopic dermatitis severity with cognitive function in adultsJonathan I Silverberg, Donald Lei, Muhammad Yousaf, et al.Journal of the American Academy of Dermatology|May 7, 2023
Prevalence and burden of atopic dermatitis involving the head, neck, face, and hand: A cross sectional study from the TARGET-DERM AD cohortJonathan I Silverberg, Brenda Simpson, Katrina Abuabara, et al.Dermatology and Therapy|July 14, 2025
Achieving Optimal Treatment Targets and Minimal Disease Activity with Upadacitinib for Moderate-to-Severe Atopic Dermatitis: Integrated Analysis of Phase 3 Studies (Measure Up 1 and 2)Jonathan I Silverberg, Melinda Gooderham, Norito Katoh, et al.Journal of the American Academy of Dermatology|January 23, 2021
Validity and reliability of Patient-Reported Outcomes Measurement Information System Global Health scale in adults with atopic dermatitisGabrielle Schwartzman, Donald Lei, Muhammad Yousaf, et al.Pageof 63